V-MAX 50 (VIRGINIAMYCIN) POWDER [PHIBRO ANIMAL HEALTH]

V-MAX 50 (VIRGINIAMYCIN) POWDER [PHIBRO ANIMAL HEALTH]
PDF | XML

NDC 66104-9601-1
Set ID de8f877b-06fe-41bc-a409-d4e5546cb5da
Category VFD TYPE A MEDICATED ARTICLE ANIMAL DRUG LABEL
Packager Phibro Animal Health
Generic Name
Product Class
Product Number
Application Number NADA140998
  • DESCRIPTION

    To be mixed in cattle feed

    Close
  • Active Drug Ingredient

    Virginiamycin : 11%

    (Contains 50 g virginiamycin activity per lb)

    Caution

     
    CAUTION: Federal law restricts medicated feed containing this veterinary feed directive (VFD) drug to use by or on the order of a licensed veterinarian.

    Inert ingredients :

    Processed grain by-products, roughage products, calcium carbonate, carboxymethylcellulose, mineral oil

    Close
  • INDICATIONS & USAGE

    Important: Must be diluted in feed before use

    Follow Directions on Back Panel

    V-Max is a registered trademark of Phibro Animal Health Corporation

    Phibro Animal Health Corporation, Teaneck, NJ 07666

    NADA #140-998, Approved by FDA

    8812000

    101-9141-05

    NET CONTENTS: 50 lb (22.7 kg)

    Distributed by:

    PHIBRO ANIMAL HEALTH, INC.

    Teaneck, NJ 07666, USA

    Close
  • (50 g virginiamycin activity per lb) For use in complete feeds for cattle fed in confinement for slaughter as specified below Directions for Use

    Cattle fed in confinement for slaughter

    Virginiamycin required mg/hd/day

    Virginiamycin (g/tons) of complete feed (90% dry matter basis)

    Reduction of incidence of liver abscesse

    85–240

    13.5–16.0

    Caution: Not for use in animals intended for breeding.

    Close
  • Mixing Directions

    Preparation ofType B Medicated Feeds for cattle fed in confinement for slaughter—Thoroughly mix the following amounts of V-Max 50 Type A Medicated Article to make 1 ton of Type B Medicated Feed to provide the concentrations shown in Table 1. An intermediate blending step, consistent with the mixing equipment specifications, should be performed to ensure adequate mixing.

    Table 1. Type B Medicated Feed

    lb of V-Max 50 Type A Medicated Article per ton of supplement

    Virginiamycin concentration in Type B Medicated Feed (g/ton)

    5

    10

    20

    40

    100

    200

    250

    500

    1,000

    2,000

    5,000

    10,000

    Preparation of Type C Medicated Feed for cattle fed in confinement for slaughter:

    From Type B Medicated Feed: The Type B Medicated Feed must be diluted to a Type C Medicated Feed before being fed. Prepare a Type B Medicated Feed as described above. Thoroughly mix the V-Max 50 Type B Medicated Feed to make 1 ton of Type C Medicated Feed to provide 13.5 16.0 g of virginiamycin per ton of complete feed on a 90% dry matter basis using the examples provided in Table 2.

    Table 2. Type C Medicated Feed prepared from V-Max 50 Type B Medicated Feed

    lb of a 500g/ton Type B Medicated Feed per ton of complete feed

    lb of a 1,000 g/ton Type B Medicated Feed per ton of complete feed

    lb of a 5,000 g/ton Type B Medicated Feed per ton of complete feed

    lb of a 10,000 g/ton Type B Medicated Feed per ton of complete feed

    Virginiamycin concentration in complete feed 90% dry matter basis (g/ton)

    54

    27

    5.4

    2.7

    13.5

    64

    32

    6.4

    3.2

    16.0

    From Type A Medicated Article: V-Max 50 Type A Medicated Article must be diluted to a Type C Medicated Feed before being fed. Thoroughly mix the Type A Medicated Article to make 1 ton of Type C Medicated Feed to provide 13.5 – 16.0 g of virginiamycin per ton of complete feed on a 90% dry matter basis using the examples provided in Table 3.

    An intermediate blending step, consistent with the blending equipment specifications, should be performed to ensure adequate mixing.

    Table 3. Type C Medicated Feed prepared from V-Max 50 Type A Medicated Article

    lb of V-Max 50 Type A Medicated Article per ton of complete feed

    Virginiamycin concentration in complete feed 90% dry matter basis (g/ton)

    0.27

    0.32

    13.5

    16.0

    Feed continuously as sole ration

    Close
  • Store at or Below 25°C/77F°, Excursions Permitted Up To 40oC (104oF)

    Close container after use

    Close
  • INDICATIONS & USAGE

    NOT FOR HUMAN USE

    RESTRICTED DRUG (CALIFORNIA) – USE ONLY AS DIRECTED

    Close
  • INGREDIENTS AND APPEARANCE
    V-MAX 50 
    virginiamycin powder
    Product Information
    Product Type VFD TYPE A MEDICATED ARTICLE ANIMAL DRUG Item Code (Source) NDC:66104-9601
    Route of Administration ORAL
    Active Ingredient/Active Moiety
    Ingredient Name Basis of Strength Strength
    VIRGINIAMYCIN (UNII: C49WS9N75L) (VIRGINIAMYCIN - UNII:C49WS9N75L) VIRGINIAMYCIN 227 g  in 0.45 kg
    Inactive Ingredients
    Ingredient Name Strength
    CALCIUM CARBONATE (UNII: H0G9379FGK)  
    MINERAL OIL (UNII: T5L8T28FGP)  
    CARBOXYMETHYLCELLULOSE SODIUM (UNII: K679OBS311)  
    Packaging
    # Item Code Package Description Marketing Start Date Marketing End Date
    1 NDC:66104-9601-1 22.7 kg in 1 BAG
    Marketing Information
    Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
    NADA NADA140998 04/01/2010
    Labeler - Phibro Animal Health (006989008)
    Registrant - Phibro Animal Health (006989008)
    Close

Related Drugs